» Articles » PMID: 32000727

Gender Differences in Treatments and Interventions Received by Children and Adolescents with Cerebral Palsy

Overview
Journal BMC Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2020 Feb 1
PMID 32000727
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the Swedish population-based follow-up program and national quality registry for individuals with cerebral palsy (CPUP), physiotherapy (PT) and occupational therapy (OT) treatments are regularly recorded along with functional status. By Swedish law, all citizens irrespective of personal characteristics or socioeconomic status, have the right to receive healthcare and medical treatments as applicable. Previous research has shown gender differences in treatments and interventions received by children with cerebral palsy (CP). The purpose of this study was to examine differences in treatments and interventions by gender and place of birth in children and adolescents participating in CPUP.

Methods: This was a cross-sectional registry study. Data from the latest PT (n = 2635) and OT assessment forms (n = 3480) in CPUP were extracted for individuals aged 0-17 years. Logistic regressions were used to assess the relationships between the outcome variables and gender and place of birth (including an interaction term gender X place of birth), adjusted for age, Gross Motor Function Classification System (GMFCS) levels and spasticity scores for PT interventions and Manual Ability Classification System (MACS) for OT interventions.

Results: Results are presented as odds ratios [95% confidence intervals] and p-values. Girls were significantly more likely to have spinal braces than boys; 1.54 [1.07, 2.22] p < 0.05, a significant interaction with place of birth indicated fewer spinal braces prescribed to children born outside of the Nordic countries; 0.20 [0.079, 0.53] p < 0.001. Girls were less likely to have undergone selective dorsal rhizotomy (SDR); 0.49 [0.25, 0.94] p < 0.05. Individuals born outside of the Nordic countries, were significantly less likely to have received intrathecal baclofen (ITB) 0.27 [0.074, 0.98] p < 0.05.

Conclusions: Of the treatments prescribed, gender differences were observed for spinal braces and having undergone SDR. A statistically significant difference based on place of birth was noted for spinal bracing and having received ITB treatment. Other PT and OT treatments were associated with age, level of spasticity, and functional severity as classified using the GMFCS and the MACS. Increased awareness of differences based on gender, and where a child is born, could be obtained by inter- and intraprofessional discussions.

Citing Articles

Research trends in the orthopedic surgical management of cerebral palsy: a cross-analytical study of publications in the past decade.

Ghandour M, Klotz M, Horsch A Front Neurol. 2023; 14:1200893.

PMID: 37681012 PMC: 10482432. DOI: 10.3389/fneur.2023.1200893.


The Non-Affected Muscle Volume Compensates for the Partial Loss of Strength after Injection of Botulinum Toxin A.

Brunner R, De Pieri E, Wyss C, Weidensteiner C, Bracht-Schweizer K, Romkes J Toxins (Basel). 2023; 15(4).

PMID: 37104205 PMC: 10141169. DOI: 10.3390/toxins15040267.


Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study.

Hagglund G, Hollung S, Ahonen M, Andersen G, Eggertsdottir G, Gaston M BMC Neurol. 2021; 21(1):276.

PMID: 34253183 PMC: 8274039. DOI: 10.1186/s12883-021-02289-3.

References
1.
Palisano R, Rosenbaum P, Bartlett D, Livingston M . Content validity of the expanded and revised Gross Motor Function Classification System. Dev Med Child Neurol. 2008; 50(10):744-50. DOI: 10.1111/j.1469-8749.2008.03089.x. View

2.
Himmelmann K, Uvebrant P . The panorama of cerebral palsy in Sweden. XI. Changing patterns in the birth-year period 2003-2006. Acta Paediatr. 2014; 103(6):618-24. DOI: 10.1111/apa.12614. View

3.
Franzen M, Hagglund G, Alriksson-Schmidt A . Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study. BMC Musculoskelet Disord. 2017; 18(1):520. PMC: 5725838. DOI: 10.1186/s12891-017-1880-y. View

4.
Sellier E, Platt M, Andersen G, Krageloh-Mann I, DE LA Cruz J, Cans C . Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol. 2015; 58(1):85-92. DOI: 10.1111/dmcn.12865. View

5.
Andersen G, Irgens L, Haagaas I, Skranes J, Meberg A, Vik T . Cerebral palsy in Norway: prevalence, subtypes and severity. Eur J Paediatr Neurol. 2007; 12(1):4-13. DOI: 10.1016/j.ejpn.2007.05.001. View